Literature DB >> 12149048

Colorectal polyps in the elderly: what should be done?

Kenneth Miller1, Jerome D Waye.   

Abstract

Colorectal cancer is an important cause of morbidity and mortality among Western nations, and is more common in the elderly than in younger individuals. With the general acceptance of the adenoma-carcinoma sequence, the current consideration is that colorectal cancer is preventable if all adenomas are removed before they have the chance to progress to cancer. To that end, physicians should now advocate screening for colorectal cancer and through this effort a large number of patients with adenomatous polyps will be discovered. It is important to understand the strategy in dealing with this growing population of patients with adenomas. After an initial polypectomy, patients with adenomas should be entered into a surveillance program to detect and remove recurrent adenomas. Recommended surveillance intervals are shorter for patients with a family history of colorectal cancer, those with multiple adenomas (>2), large adenomas (> or = 1cm), or those whose adenomas have high-grade dysplasia, villous architecture, or that are cancerous. Effective chemoprevention would be a potential method of lengthening colonoscopic surveillance intervals. Unfortunately, no treatment has been found to be effective enough to alter our current surveillance practice. The only recommendation that can be made at this time for those patients with a history of colonic adenomas is to add 3 g/day of calcium carbonate to their diet, though its effect on adenoma recurrence is modest.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12149048     DOI: 10.2165/00002512-200219060-00001

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  78 in total

1.  Non-steroidal anti-inflammatory drugs and ulcer complications: a risk factor analysis for clinical decision-making.

Authors:  J M Hansen; J Hallas; J M Lauritsen; P Bytzer
Journal:  Scand J Gastroenterol       Date:  1996-02       Impact factor: 2.423

Review 2.  Colon cancer screening. Sigmoidoscopy or colonoscopy.

Authors:  S K Khullar; J A DiSario
Journal:  Gastrointest Endosc Clin N Am       Date:  1997-07

3.  Rectal cancer in FAP patient after sulindac.

Authors:  A G Thorson; H T Lynch; T C Smyrk
Journal:  Lancet       Date:  1994-01-15       Impact factor: 79.321

4.  Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women.

Authors:  W C Willett; M J Stampfer; G A Colditz; B A Rosner; F E Speizer
Journal:  N Engl J Med       Date:  1990-12-13       Impact factor: 91.245

5.  Aspirin and nonsteroidal anti-inflammatory agents and risk for colorectal adenomas.

Authors:  R S Sandler; J C Galanko; S C Murray; J F Helm; J T Woosley
Journal:  Gastroenterology       Date:  1998-03       Impact factor: 22.682

6.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.

Authors:  J D Hardcastle; J O Chamberlain; M H Robinson; S M Moss; S S Amar; T W Balfour; P D James; C M Mangham
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

7.  Natural history of untreated colonic polyps.

Authors:  S J Stryker; B G Wolff; C E Culp; S D Libbe; D M Ilstrup; R L MacCarty
Journal:  Gastroenterology       Date:  1987-11       Impact factor: 22.682

8.  Effect of sulindac on sporadic colonic polyps.

Authors:  J Ladenheim; G Garcia; D Titzer; H Herzenberg; P Lavori; R Edson; M B Omary
Journal:  Gastroenterology       Date:  1995-04       Impact factor: 22.682

9.  Nonsteroidal anti-inflammatory drug use and sporadic colorectal adenomas.

Authors:  R N DuBois
Journal:  Gastroenterology       Date:  1995-04       Impact factor: 22.682

10.  Low-dose aspirin and incidence of colorectal tumors in a randomized trial.

Authors:  P H Gann; J E Manson; R J Glynn; J E Buring; C H Hennekens
Journal:  J Natl Cancer Inst       Date:  1993-08-04       Impact factor: 13.506

View more
  2 in total

Review 1.  New dosage formulations for targeted delivery of cyclo-oxygenase-2 inhibitors: focus on use in the elderly.

Authors:  Shyam S Bansal; Abhijeet Joshi; Arvind K Bansal
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

2.  Four-week short chain fructo-oligosaccharides ingestion leads to increasing fecal bifidobacteria and cholesterol excretion in healthy elderly volunteers.

Authors:  Yoram Bouhnik; Lotfi Achour; Damien Paineau; Michel Riottot; Alain Attar; Francis Bornet
Journal:  Nutr J       Date:  2007-12-05       Impact factor: 3.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.